A Trial to Evaluate the Immunogenicity of Accelerated Primary Vaccination With Monovalent A/Indonesia/5/05 (H5N1) Vaccine Antigen in Association With AS03 Adjuvant in Adults Aged 18-64

The purpose of the study is to characterize the immunogenicity & safety of 2 doses of GSK's avian flu vaccine GSK 1557484A given according to different regimens to adults aged 18 to 64 years

Bibliographic Details
Main Author: GlaxoSmithKline
Format: Dataset
Language:unknown
Published: Vivli 2018
Subjects:
Online Access:https://dx.doi.org/10.25934/00000648
https://search.vivli.org/doiLanding/studies/00000648/isLanding
id ftdatacite:10.25934/00000648
record_format openpolar
spelling ftdatacite:10.25934/00000648 2023-05-15T15:34:16+02:00 A Trial to Evaluate the Immunogenicity of Accelerated Primary Vaccination With Monovalent A/Indonesia/5/05 (H5N1) Vaccine Antigen in Association With AS03 Adjuvant in Adults Aged 18-64 GlaxoSmithKline 2018 https://dx.doi.org/10.25934/00000648 https://search.vivli.org/doiLanding/studies/00000648/isLanding unknown Vivli Study data may be accessed by completing a request form at https://vivli.org. It will then be reviewed according to the data contributor’s governance policy, see https://vivli.org/members/ourmembers/ for Vivli member’s review process. If approved, use of the data is governed by the data use agreement at https://vivli.org/resources/vivli-data-use-agreement/ Conditions Influenza Interventions Influenza A H5N1 Virus Monovalent Vaccine dataset Dataset 2018 ftdatacite https://doi.org/10.25934/00000648 2022-02-08T14:28:24Z The purpose of the study is to characterize the immunogenicity & safety of 2 doses of GSK's avian flu vaccine GSK 1557484A given according to different regimens to adults aged 18 to 64 years Dataset Avian flu DataCite Metadata Store (German National Library of Science and Technology)
institution Open Polar
collection DataCite Metadata Store (German National Library of Science and Technology)
op_collection_id ftdatacite
language unknown
topic Conditions Influenza
Interventions Influenza A H5N1 Virus Monovalent Vaccine
spellingShingle Conditions Influenza
Interventions Influenza A H5N1 Virus Monovalent Vaccine
GlaxoSmithKline
A Trial to Evaluate the Immunogenicity of Accelerated Primary Vaccination With Monovalent A/Indonesia/5/05 (H5N1) Vaccine Antigen in Association With AS03 Adjuvant in Adults Aged 18-64
topic_facet Conditions Influenza
Interventions Influenza A H5N1 Virus Monovalent Vaccine
description The purpose of the study is to characterize the immunogenicity & safety of 2 doses of GSK's avian flu vaccine GSK 1557484A given according to different regimens to adults aged 18 to 64 years
format Dataset
author GlaxoSmithKline
author_facet GlaxoSmithKline
author_sort GlaxoSmithKline
title A Trial to Evaluate the Immunogenicity of Accelerated Primary Vaccination With Monovalent A/Indonesia/5/05 (H5N1) Vaccine Antigen in Association With AS03 Adjuvant in Adults Aged 18-64
title_short A Trial to Evaluate the Immunogenicity of Accelerated Primary Vaccination With Monovalent A/Indonesia/5/05 (H5N1) Vaccine Antigen in Association With AS03 Adjuvant in Adults Aged 18-64
title_full A Trial to Evaluate the Immunogenicity of Accelerated Primary Vaccination With Monovalent A/Indonesia/5/05 (H5N1) Vaccine Antigen in Association With AS03 Adjuvant in Adults Aged 18-64
title_fullStr A Trial to Evaluate the Immunogenicity of Accelerated Primary Vaccination With Monovalent A/Indonesia/5/05 (H5N1) Vaccine Antigen in Association With AS03 Adjuvant in Adults Aged 18-64
title_full_unstemmed A Trial to Evaluate the Immunogenicity of Accelerated Primary Vaccination With Monovalent A/Indonesia/5/05 (H5N1) Vaccine Antigen in Association With AS03 Adjuvant in Adults Aged 18-64
title_sort trial to evaluate the immunogenicity of accelerated primary vaccination with monovalent a/indonesia/5/05 (h5n1) vaccine antigen in association with as03 adjuvant in adults aged 18-64
publisher Vivli
publishDate 2018
url https://dx.doi.org/10.25934/00000648
https://search.vivli.org/doiLanding/studies/00000648/isLanding
genre Avian flu
genre_facet Avian flu
op_rights Study data may be accessed by completing a request form at https://vivli.org. It will then be reviewed according to the data contributor’s governance policy, see https://vivli.org/members/ourmembers/ for Vivli member’s review process. If approved, use of the data is governed by the data use agreement at https://vivli.org/resources/vivli-data-use-agreement/
op_doi https://doi.org/10.25934/00000648
_version_ 1766364727030579200